Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Zhong Yuan Bio-Technology Holdings EPS (Diluted) Related Terms
Zhong Yuan Bio-Technology Holdings EPS (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZHYBF vs CLNN, JVA, STCB: EPS (Diluted) Comparison
For the Packaged Foods subindustry, Zhong Yuan Bio-Technology Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhong Yuan Bio-Technology Holdings PE Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Zhong Yuan Bio-Technology Holdings's PE Ratio distribution charts can be found below:
* The bar in red indicates where Zhong Yuan Bio-Technology Holdings's PE Ratio falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhong Yuan Bio-Technology Holdings (ZHYBF) has a EPS (Diluted) of $0.02 as of Mar. 2024. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Zhong Yuan Bio-Technology Holdings and its competitors.
Is Zhong Yuan Bio-Technology Holdings' EPS (Diluted) too high?
Zhong Yuan Bio-Technology Holdings' current EPS (Diluted) is $0.02. Overall, Zhong Yuan Bio-Technology Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Zhong Yuan Bio-Technology Holdings' EPS (Diluted) compare to CLNN and JVA?
Zhong Yuan Bio-Technology Holdings' EPS (Diluted) of $0.02 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Consumer Packaged Goods company?
A good EPS (Diluted) depends on the Consumer Packaged Goods industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Zhong Yuan Bio-Technology Holdings and its competitors. Zhong Yuan Bio-Technology Holdings's current EPS (Diluted) is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhong Yuan Bio-Technology Holdings stock overvalued right now?
Zhong Yuan Bio-Technology Holdings (ZHYBF) has a current EPS (Diluted) of $0.02. The current EPS (Diluted) is $0.02. Zhong Yuan Bio-Technology Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Zhong Yuan Bio-Technology Holdings (ZHYBF), the current EPS (Diluted) is $0.02 as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.
12GF Score
Get the complete analysis for ZHYBF
EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZHYBF has been successfully added to your 
